fluoxetine and 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine

fluoxetine has been researched along with 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Audinot, V; Brocco, M; Cistarelli, L; Gobert, A; Lacroix, P; Millan, MJ; Newman-Tancredi, A; Rivet, JM	1

Other Studies

1 other study(ies) available for fluoxetine and 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine

Article	Year
S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:1 Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Fluoxetine; Frontal Lobe; Humans; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists	1997

Article

Year

S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of

The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:1

Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Fluoxetine; Frontal Lobe; Humans; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists

1997